How should I manage a patient with serum iron 35 µg/dL, ferritin 11 µg/L, hemoglobin 9.8 g/dL, reticulocyte count 1.8%, who is taking ferrous sulfate 325 mg and has a poor iron‑rich diet?

Management of Iron Deficiency Anemia with Poor Oral Iron Response

Continue the ferrous sulfate 325 mg but reduce to once daily dosing (or every-other-day if not tolerated), add 500 mg vitamin C with each dose, monitor hemoglobin response at 4 weeks, and if hemoglobin fails to increase by ≥1 g/dL or ferritin remains <30 µg/L, switch to intravenous iron immediately. 1, 2

Current Clinical Picture Analysis

Your patient has clear iron deficiency anemia with:

• Hemoglobin 9.8 g/dL (anemic)
• Ferritin 11 µg/L (severely depleted iron stores)
• Serum iron 35 µg/dL (low)
• Reticulocyte count 1.8% (inadequate bone marrow response)

The reticulocyte count of 1.8% is concerning—this should be elevated in response to anemia if iron were adequately available for erythropoiesis. This suggests functional iron deficiency despite oral supplementation 3, 4.

Immediate Optimization of Current Oral Therapy

Dosing Adjustment

Reduce to once-daily dosing maximum. The current 325 mg ferrous sulfate provides 65 mg elemental iron 5. Taking iron more than once daily increases hepcidin levels for up to 48 hours, which paradoxically blocks further iron absorption while dramatically increasing gastrointestinal side effects 2. Recent evidence shows once-daily or every-other-day dosing achieves similar absorption with better tolerance 2, 6.

Add Vitamin C

Prescribe 500 mg vitamin C with each iron dose. This enhances absorption by chelating iron and reducing ferric to ferrous form, allowing absorption even in the presence of dietary inhibitors 2. Take on an empty stomach if tolerated; if not, taking with food is acceptable but avoid tea and coffee within 1 hour 2.

Dietary Counseling

Address the "poor diet" specifically:

• Increase heme iron sources (red meat, poultry, fish)
• Avoid tea and coffee within 1 hour of iron dosing (powerful absorption inhibitors) 2
• Consider nutritionist referral for structured dietary iron optimization 2

Critical 4-Week Monitoring Point

At 4 weeks, measure hemoglobin and ferritin 1. This is your decision point:

Expected Response to Adequate Oral Iron:

• Hemoglobin should increase by ≥1 g/dL within 2 weeks (to ≥10.8 g/dL by week 2-4) 2, 6
• Ferritin should show measurable increase within 1 month 2

If Response is Inadequate:

Switch to intravenous iron immediately. Do not continue ineffective oral therapy 1, 2.

When to Use Intravenous Iron

IV iron is indicated if:

1. No hemoglobin increase of ≥1 g/dL by 2-4 weeks 2
2. Ferritin fails to rise after 1 month of adherent oral therapy 2
3. Patient cannot tolerate oral iron (gastrointestinal side effects) 1, 2
4. Ongoing blood loss exceeds oral absorption capacity 2

Preferred IV formulations: Use single or 2-infusion protocols (ferric carboxymaltose, iron isomaltoside, or low-molecular-weight iron dextran) rather than multiple-dose regimens 2. These achieve dramatically superior iron store repletion—recent data shows 47-fold higher ferritin levels (412 vs 8.7 µg/L) compared to continued oral therapy 7.

IV Iron Safety

True anaphylaxis is extremely rare (1:200,000). Most reactions are complement activation-related pseudo-allergy (infusion reactions, ~1:200), managed by stopping and restarting at slower rate 2. Avoid diphenhydramine as side effects mimic worsening reactions 2.

Treatment Duration and Targets

Continue iron therapy for 3 months after hemoglobin normalization to replenish bone marrow iron stores 1. Target ferritin >30 µg/L minimum, ideally >100 µg/L for adequate store repletion 1, 8.

Investigate Underlying Cause

While optimizing iron replacement, investigate the source of iron deficiency:

• Gastrointestinal evaluation: In adults with new IDA, gastroscopy and colonoscopy are first-line investigations to exclude bleeding sources or malabsorption (celiac disease, H. pylori) 1
• Gynecologic assessment: If premenopausal woman, evaluate for menorrhagia or other gynecologic blood loss 2, 9
• Dietary assessment: Quantify actual dietary iron intake 2

Do not defer iron replacement while awaiting investigations unless colonoscopy is imminent 1.

Common Pitfalls to Avoid

1. Continuing ineffective oral iron indefinitely: If no response by 4 weeks, switch to IV 2
2. Multiple daily dosing: Increases side effects without improving absorption 2
3. Stopping treatment when hemoglobin normalizes: Continue 3 months longer to replenish stores 1
4. Overlooking malabsorption: Poor response despite adherence suggests absorption problem requiring IV iron 2
5. Missing ongoing blood loss: If IDA recurs after adequate treatment, investigate further 1